>
Switch to:

Allergy Therapeutics Market Cap

: $303.3 Mil (As of Today)
View and export this data going back to 2004. Start your Free Trial

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Allergy Therapeutics's share price for the quarter that ended in Jun. 2021 was $0.23. Allergy Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Jun. 2021 was 651.6 Mil. Therefore, Allergy Therapeutics's market cap for the quarter that ended in Jun. 2021 was $149.9 Mil.

Allergy Therapeutics's quarterly market cap declined from Jun. 2020 ($95.6 Mil) to Dec. 2020 ($64.1 Mil) but then increased from Dec. 2020 ($64.1 Mil) to Jun. 2021 ($149.9 Mil).

Allergy Therapeutics's annual market cap declined from Jun. 2019 ($108.1 Mil) to Jun. 2020 ($95.6 Mil) but then increased from Jun. 2020 ($95.6 Mil) to Jun. 2021 ($149.9 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Allergy Therapeutics's Enterprise Value for Today is $264.6 Mil.


Allergy Therapeutics Market Cap Historical Data

The historical data trend for Allergy Therapeutics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Market Cap
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 196.06 178.85 108.15 95.59 149.87

Allergy Therapeutics Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Market Cap Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 108.15 108.15 95.59 64.08 149.87

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Allergy Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Allergy Therapeutics Market Cap Distribution

For the Drug Manufacturers industry and Healthcare sector, Allergy Therapeutics's Market Cap distribution charts can be found below:

* The bar in red indicates where Allergy Therapeutics's Market Cap falls into.



Allergy Therapeutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Allergy Therapeutics's Market Cap for the fiscal year that ended in Jun. 2021 is calculated as

Market Cap (A: Jun. 2021 )=Share Price (A: Jun. 2021 )*Shares Outstanding (EOP) (A: Jun. 2021 )
=$0.23*651.621
=$149.9

Allergy Therapeutics's Market Cap for the quarter that ended in Jun. 2021 is calculated as

Market Cap (Q: Jun. 2021 )=Share Price (Q: Jun. 2021 )*Shares Outstanding (EOP) (Q: Jun. 2021 )
=$0.23*651.621
=$149.9

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allergy Therapeutics  (OTCPK:AGYTF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Allergy Therapeutics Market Cap Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Allergy Therapeutics Business Description

Allergy Therapeutics logo
Industry
Traded in Other Exchanges
Address
Dominion Way, Worthing, West Sussex, GBR, BN14 8SA
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics Headlines

No Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)